Successful Proof-of-Concept for Topical Delivery of Novel Peptide ALM201 with Potential Usefulness for Treating Neovascular Eye Disorders

par Gideon Obasanmi, PhD, M. Andrew Nesbit, PhD, Diego Cobice, PhD, Logan Mackay, PhD, Stuart McGimpsey, MBBCh, BAO, Mark Wappett, MRes, Aaron N. Cranston, PhD, Tara C.B. Moore, PhD
Publié 2022-06-01